Abstract
Surgery is the standard therapy for esophageal cancer,however,the postoperative overall survival rate is still disappointed.Local recurrence and regional lymph node metastasis are the main failure models.The optimal therapeutic modality for these patients with radical resection remains unclear.Some researches indicate that patients with stage Ⅲ,N1 can benefit from postoperative radiotherapy,which can improve the disease-free survival and overall survival ratio.The irradiation field depends on the site of tumor removal (tumor bed) during surgery.The cisplatin plus 5-fluorouracil chemotherapy regimen seems as the preferred for postoperative adjuvant chemotherapy,the mainly adverse reactions are digestive tract reactions and myelosuppression.The clinical value of postoperative adjuvant chemoradiotherapy still needs more clinical trials to support. Key words: Esophageal neoplasms; Esophagectomy; Neoadjuvant therapy
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
